[mc4wp_form id="313"]

Celgene’s drug for anemia in beta thalassemia priced at $3,441/ 25 mg vial

Share this post

Celgene Corp’s treatment for anemia in patients with beta thalassemia, a rare blood disorder, would be priced at $3,441 for a 25-milligram vial of the drug, partner Acceleron Pharma Inc said.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply